Good morning, everyone, and welcome to the ImmuCell Corporation conference call to discuss strategic change in focus and unaudited 2025 sales results. [Operator Instructions] Please also note, today's ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

Create a Physics World account to get access to all available digital issues of the monthly magazine. Your Physics World ...

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, today ...

According to MarketsandMarkets™, the Human Microbiome Drugs Market is projected to grow from about USD 0.35 billion in 2025 ...

Jubilant Biosys Limited. Jubilant Biosys Doubles Early Chemistry Scale-Up Capacity with New Noida Facility in India. Press ...

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health company that develops, manufactures and markets products that improve ...

According to MarketsandMarkets, the Human Microbiome Drugs Market is projected to grow from about USD 0.35 billion in 2025 to USD 2.13 billion ...

Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, and a global CRDMO operating from five sites across India and Europe, – announced the opening of a new discovery and ...

Foams were once thought to behave like glass, with bubbles frozen in place at the microscopic level. But new simulations ...